3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
10
Breast Neoplasms
9
Colonic Neoplasms
6
Carcinoma, Non-Small-Cell Lung
5
Rectal Neoplasms
4
Lung Neoplasms
4
Head and Neck Neoplasms
4
Adenomatous Polyposis Coli
4
Sarcoma
3
Glioblastoma
3
Central Nervous System Neoplasms
3
Paranasal Sinus Neoplasms
2
Neoplasms
2
Mouth Neoplasms
2
Melanoma
2
Laryngeal Neoplasms
2
Gliosarcoma
2
Breast Carcinoma In Situ
2
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Triple Negative Breast Neoplasms
1
Tobacco Use Disorder
1
Stomatitis
1
Smoldering Multiple Myeloma
1
Smoking
1
Recurrence
1
Prostatic Neoplasms
1
Prostatic Hyperplasia
1
Precancerous Conditions
1
Interventions
Irinotecan
7
Cyclophosphamide
7
Vincristine
6
Magnetic Resonance Spectroscopy
5
Dactinomycin
5
temsirolimus
4
cixutumumab
4
X-Rays
4
Sirolimus
4
Radiotherapy
4
Phantoms, Imaging
4
Etoposide
4
Doxorubicin
4
Specimen Handling
3
Radiation
3
Peripheral Blood Stem Cell Transplantation
3
Nuclear Medicine Department, Hospital
3
Melphalan
3
Ifosfamide
3
Gemcitabine
3
Filgrastim
3
ulixertinib
2
tipifarnib
2
thymoglobulin
2
tazemetostat
2
selpercatinib
2
palbociclib
2
olaparib
2
larotrectinib
2
ivosidenib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Rhabdomyosarcoma
×
Celecoxib
×
Clear all
No trials found.